Company: RGNT
Filing Date: 2025-07-07
Form Type: F-1/A
Source: 0001213900-25-061821
Chunk: 126

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-07-07
Form: F-1/A
Chunk 126
---
 This patent
may be useful to supplement the protection of GelrinC which may contain albumin as well as fibrinogen.

Patents derived from or related to WO 2015/052708 filed on January 24, 2014 claim an apparatus or method for treatment of cavities in a human body. The patent applications derived include patents Nos. US 9,895,519, US 9,872,705, EP 2874546(validated in Germany, France
and the United Kingdom), CN 106232023 and IL 235270, which are detailed in the table below.

The patent portfolio of the
Company includes granted patents that cover the products currently in development and additional families of patents that may provide
supplementary protection for those products and further products.

<div align='center'>76</div>

Patents

As of April 7, 2025, our exclusively owned patent portfolio includes thirty-four (34) issued patents, of which eight (8) are U.S. patents and twenty-six (26) are foreign patents, with eighteen (18) of the twenty-six (26) foreign patents being nationally validated in certain European extension/validation states). In addition, one U.S. patent application and three patent applications are pending. The claims of the owned patents and patent applications below are directed toward various aspects of our family of products, methods of their manufacturing, delivery device and research programs.

| Effective     
 Filing Date   |     | Patent     
 No.        |     | Title                                                                                         |     | Country                 |     | Product         |     | Type              
 of                
 patent protection |     | Expiry date1 |
| Dec. 15, 2004 |     | US         
 8,007,774  |     | Matrix composed of a naturally-occurring                                                      
 protein backbone cross linked by a synthetic polymer and methods of generating and using same |     | USA                     |     | Gelrin          |     | Utility patent    |     | Dec.         
 31, 20252    |
| Dec. 15, 2004 |     | US         
 9,120,872  |     | Matrix composed of a naturally-occurring                                                      
 protein backbone cross linked by a synthetic polymer and methods of generating and using same |     | USA                     |     | Gelrin          |     | Utility patent    |     | Dec.         
 31, 20252    |
| Dec. 15, 2004 |     | US